Who owns NEUMORA THERAPEUTICS INC.?
- Ticker: NMRA
- CUSIP Number: 640979100
Tip: Access positions for across all investors
Analyze quarterly positions in Neumora Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Neumora Therapeutics stock
Who bought or sold NEUMORA THERAPEUTICS INC. this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Softbank Group Corp | 6.4M | $12M | -2% | Dec 2025 |
|
| Siren | 6.3M | $11M | 44% | Dec 2025 |
|
| Vanguard Group | 4.5M | $8.1M | 12% | Dec 2025 |
|
| MIC Capital Management UK | 4.5M | $8.0M | 0% | Dec 2025 |
|
| Point72 Asset Management | 3.7M | $6.6M | 100% | Dec 2025 |
|
| Millennium Management | 3.6M | $6.5M | 80% | Dec 2025 |
|
| FMR | 3.5M | $6.3M | 0% | Dec 2025 |
|
| Wellcome Trust Limited, as Trustee of the Wellcome Trust | 3.3M | $5.9M | 0% | Dec 2025 |
|
| ICONIQ Capital | 2.6M | $4.6M | 0% | Dec 2025 |
|
| Lunate Capital | 2.1M | $4.1M | 0% | Mar 2026 |
|
| BlackRock | 2.0M | $3.6M | 12% | Dec 2025 |
|
| Johnson & Johnson | 1.8M | $3.3M | 0% | Dec 2025 |
|
| Renaissance Technologies | 1.4M | $2.6M | 24% | Dec 2025 |
|
| Two Sigma Investments | 1.3M | $2.3M | 336% | Dec 2025 |
|
| Ikarian Capital | 1.3M | $2.3M | 10129% | Dec 2025 |
|
| Jane Street | 1.1M | $2.0M | 526% | Dec 2025 |
|
| Two Sigma Advisers | 1.1M | $1.9M | 11% | Dec 2025 |
|
| Geode Capital Management | 1.0M | $1.8M | 4% | Dec 2025 |
|
| Tang Capital Management | 967k | $1.7M | -31% | Dec 2025 |
|
| Goldman Sachs Group | 859k | $1.5M | 127% | Dec 2025 |
|
| Susquehanna International | 799k | $1.4M | 68% | Dec 2025 |
|
| AlphaCore Capital | 639k | $1.1M | 0% | Dec 2025 |
|
| Marshall Wace | 584k | $1.0M | 100% | Dec 2025 |
|
| Citadel Advisors | 553k | $990k | 281% | Dec 2025 |
|
| GSA Capital Partners | 534k | $956k | 393% | Dec 2025 |
|
| Charles Schwab Investment Management | 513k | $917k | 0% | Dec 2025 |
|
| Jacobs Levy Equity Management | 475k | $849k | -43% | Dec 2025 |
|
| State Street Corporation | 389k | $696k | 0% | Dec 2025 |
|
| Boothbay Fund Management | 335k | $600k | 100% | Dec 2025 |
|
| Federated Investors | 314k | $562k | 0% | Dec 2025 |
|
| HPM Partners | 275k | $493k | -5% | Dec 2025 |
|
| Acadian Asset Management | 239k | $426k | -12% | Dec 2025 |
|
| Invesco | 228k | $407k | 24% | Dec 2025 |
|
| Bridgeway Capital Management | 225k | $403k | 0% | Dec 2025 |
|
| Graham Capital Management | 191k | $343k | 22% | Dec 2025 |
|
| Squarepoint Ops | 186k | $333k | 1355% | Dec 2025 |
|
| Northern Trust | 185k | $332k | 17% | Dec 2025 |
|
| ExodusPoint Capital Management | 181k | $324k | 100% | Dec 2025 |
|
| Addis & Hill | 163k | $319k | 0% | Mar 2026 |
|
| EntryPoint Capital | 145k | $260k | 100% | Dec 2025 |
|
| OMERS Administration Corporation | 137k | $246k | 100% | Dec 2025 |
|
| XTX Topco | 114k | $204k | 100% | Dec 2025 |
|
| Dimensional Fund Advisors | 107k | $192k | 2% | Dec 2025 |
|
| Rbf Capital | 105k | $188k | -25% | Dec 2025 |
|
| SkyOak Wealt | 100k | $179k | 0% | Dec 2025 |
|
| Virtu Financial | 97k | $174k | 466% | Dec 2025 |
|
| UBS Group | 95k | $170k | -26% | Dec 2025 |
|
| AQR Capital Management | 94k | $169k | -55% | Dec 2025 |
|
| Canada Pension Plan Investment Board | 92k | $164k | 100% | Dec 2025 |
|
| Meridian Wealth Management | 86k | $155k | 45% | Dec 2025 |
|
| Northwestern Mutual Wealth Management Company | 77k | $137k | 0% | Dec 2025 |
|
| Susquehanna Portfolio Strategies | 72k | $129k | 75% | Dec 2025 |
|
| JustInvest | 65k | $116k | 1% | Dec 2025 |
|
| ADAR1 Capital Management | 51k | $91k | 100% | Dec 2025 |
|
| Leucadia National Corporation | 44k | $79k | -5% | Dec 2025 |
|
| Amg National Trust Bank | 43k | $78k | 0% | Dec 2025 |
|
| Bank of New York Mellon | 39k | $70k | 98% | Dec 2025 |
|
| American Century Companies | 39k | $70k | 100% | Dec 2025 |
|
| Sig Brokerage | 33k | $59k | -6% | Dec 2025 |
|
| Voleon Capital Management | 31k | $56k | 100% | Dec 2025 |
|
| Barclays | 31k | $55k | 202% | Dec 2025 |
|
| Catalyst Funds Management Pty | 30k | $53k | 0% | Dec 2025 |
|
| China Universal Asset Management | 27k | $49k | -4% | Dec 2025 |
|
| Fred Alger Management | 22k | $40k | 100% | Dec 2025 |
|
| Walleye Trading Advisors | 21k | $38k | 100% | Dec 2025 |
|
| Legacy Private Trust | 19k | $37k | 0% | Mar 2026 |
|
| Tower Research Capital | 18k | $32k | -16% | Dec 2025 |
|
| SG Americas Securities | 17k | $33k | -74% | Mar 2026 |
|
| HBK Sorce Advisory | 17k | $36k | 1% | Dec 2025 |
|
| Clarius | 17k | $30k | 0% | Dec 2025 |
|
| Hsbc Holdings | 15k | $27k | 100% | Dec 2025 |
|
| Woodline Partners | 15k | $27k | 0% | Dec 2025 |
|
| Ieq Capital | 13k | $24k | -25% | Dec 2025 |
|
| Walleye Trading | 13k | $23k | 100% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 12k | $22k | 361% | Dec 2025 |
|
| Quadrature Capital | 11k | $20k | 100% | Dec 2025 |
|
| Creative Planning | 11k | $20k | 100% | Dec 2025 |
|
| Wells Fargo & Company | 10k | $18k | 100% | Dec 2025 |
|
| Mirae Asset Global Investments | 8.1k | $15k | 30% | Dec 2025 |
|
| CWM | 5.2k | $9.0k | -54% | Dec 2025 |
|
| Gf Fund Management | 3.7k | $7.3k | 14% | Mar 2026 |
|
| Rhumbline Advisers | 2.6k | $4.6k | 0% | Dec 2025 |
|
| NISA Investment Advisors | 1.5k | $2.6k | 0% | Dec 2025 |
|
| UMA Financial Services | 1.3k | $2.4k | 0% | Dec 2025 |
|
| Pnc Financial Services | 1.0k | $1.8k | 0% | Dec 2025 |
|
| Optiver Holding B.V. | 592.00 | $1.1k | 100% | Dec 2025 |
|
| Daiwa Securities Group | 533.00 | $1.0k | 0% | Dec 2025 |
|
| EverSource Wealth Advisors | 319.00 | $574.200000 | -5% | Dec 2025 |
|
| Parallel Advisors | 279.00 | $498.991500 | 100% | Dec 2025 |
|
| Optima Capital | 270.00 | $483.003000 | 100% | Dec 2025 |
|
| Signature | 264.00 | $515.011200 | 100% | Mar 2026 |
|
| Centerpoint Advisors | 220.00 | $0 | 100% | Dec 2025 |
|
| Fortitude Family Office | 167.00 | $326.000700 | -84% | Mar 2026 |
|
| Capital Advisors | 145.00 | $0 | 0% | Mar 2026 |
|
| SBI Securities | 19.00 | $34.000500 | 6% | Dec 2025 |
|
| Caitong International Asset Management | 5.00 | $9.000000 | 100% | Dec 2025 |
|
Who sold out of Neumora Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| T. Rowe Price Investment Management | Sep 2025 | 1.9M | $3.5M |
| Ameriprise Financial | Sep 2025 | 118k | $214k |
| Sei Investments | Sep 2025 | 68k | $124k |
| Peak6 | Sep 2025 | 56k | $103k |
| Ohio Pers | Sep 2025 | 24k | $44k |
| R Squared | Sep 2025 | 13k | $24k |
| SRS Capital Advisors | Sep 2025 | 12k | $23k |
| Engineers Gate Manager | Sep 2025 | 12k | $22k |
| Simplex Trading | Sep 2025 | 8.5k | $15k |